Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,507.60
(
-0.05%
)
Dow Jones
46,208.47
(
0.00%
)
Brent Oil
98.78
(
2.05%
)
Bitcoin
71,261.00
(
0.51%
)
News Focus
News Focus
Post# of 257273
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: mcbio post# 163899

Friday, 07/12/2013 8:45:25 AM

Friday, July 12, 2013 8:45:25 AM

Post# of 257273

It is precisely these reasons you cite, namely the fact that GILD has a lot to recoup from the VRUS purchase, that leads me to believe that the competition will be able to carve out a nice niche competing on price.





Great point and the true value driver for simeprevir in emerging markets.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today